Raphael Pharmaceutical Inc. is a pharmaceutical research and development company focused on cannabinoid-based drug therapies, including CBD oil. Its lead product candidate targets rheumatoid arthritis (RA), with a proof-of-concept clinical study completed in December 2024. The company also develops candidates for asthma and COVID-19, and launched RaphaWell, a dietary supplement for RA support, under IRB-approved clinical testing in the U.S.
expected 2026-12-01
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001213900-26-037402 | EDGAR | 62K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-026214 | EDGAR | 60K words |
| 2024-03-28 | 2023-12-31 | 0001213900-24-027234 | EDGAR | 56K words |
| 2023-03-24 | 2022-12-31 | 0001213900-23-022628 | EDGAR | 55K words |
| 2022-03-30 | 2021-12-31 | 0001213900-22-015973 | EDGAR | 50K words |
| 2010-04-19 | 2009-12-31 | 0001165527-10-000304 | EDGAR | — |
| 2009-03-27 | 2008-12-31 | 0001165527-09-000198 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001213900-26-089975 | EDGAR | 11K words |
| 2025-11-13 | 2025-09-30 | 0001213900-25-109968 | EDGAR | 12K words |
| 2025-08-13 | 2025-06-30 | 0001213900-25-075662 | EDGAR | 11K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-043641 | EDGAR | 11K words |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098456 | EDGAR | 9K words |
| 2024-08-12 | 2024-06-30 | 0001213900-24-067723 | EDGAR | 9K words |
| 2024-05-15 | 2024-03-31 | 0001213900-24-043557 | EDGAR | 9K words |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086894 | EDGAR | 9K words |
| 2023-08-09 | 2023-06-30 | 0001213900-23-065005 | EDGAR | 9K words |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039833 | EDGAR | 8K words |
| 2022-11-14 | 2022-09-30 | 0001213900-22-071861 | EDGAR | 10K words |
| 2022-08-12 | 2022-06-30 | 0001213900-22-047195 | EDGAR | 9K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-01 | 0001213900-26-096113 | EDGAR | 9K words |
| 2026-07-17 | 0001213900-26-078937 | EDGAR | 1K words |
| 2026-03-24 | 0001213900-26-033507 | EDGAR | 1K words |
| 2025-08-11 | 0001213900-25-074293 | EDGAR | 1K words |
| 2025-08-11 | 0001213900-25-073909 | EDGAR | 1K words |
| 2025-01-14 | 0001213900-25-003401 | EDGAR | 1K words |
| 2024-12-30 | 0001213900-24-113467 | EDGAR | 1K words |
| 2024-09-11 | 0001213900-24-077706 | EDGAR | 1K words |
| 2024-06-26 | 0001213900-24-056191 | EDGAR | 1K words |
| 2024-05-02 | 0001213900-24-039106 | EDGAR | 1K words |
73 total filings indexed. 44 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001415397 |
| Ticker | RAPH |
| Exchange | OTC |
| SIC | 2833: Medicinal Chemicals & Botanical Products |
| Incorporated | NV |
| Headquarters | Nevada (incorporated); clinical work in Santa Monica, California and Israel |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RAPH (~200 tokens, structured JSON with cryptographic provenance)